Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELQG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,397
Award facts
- Contract value 100% obligated
- $12,396.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order was issued on November 24, 2025, with an ultimate completion date of November 25, 2025, and carries no set-aside designation. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support federal healthcare operations, leveraging its established capabilities as a critical supplier within the Department of Defense pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion governmentwide acquisition strategy. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. The company's extensive product portfolio and demonstrated performance across multiple delivery orders reflect its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FELQG?
SPE2DU26FELQG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DU26FELQG worth?
The government has obligated $12,397 on SPE2DU26FELQG.
Is contract SPE2DU26FELQG an order under another contract?
Yes. SPE2DU26FELQG is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELQG competed?
The extent of competition for SPE2DU26FELQG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award